Which first-line dressing to choose for patients with chronic wounds?

What is it about?

Chronic wounds such as diabetic foot ulcers , leg ulcers or pressure injuries/ulcers are nowadays a clinical, social and economic burden for health care systems. These kind of ulcers are often at risk of local infection and other complications that can require hospitalization and in some severe cases are potentially limb and/or life-threatening. Chronic wounds are often associated with significant local pain, disability and reduced quality of life. These patients require a holistic management including the best wound care to promote healing and improve healing time.

Featured Image

Photo by Ani Kolleshi on Unsplash

Photo by Ani Kolleshi on Unsplash

Why is it important?

Our findings show that the use of Lipidocolloid technology with a nano-oligosaccharide factor (TLC-NOSF) dressings as a first-line treatment for chronic wounds has showed significant improvement in wound healing rates, shorter healing times, and cost savings compared with standard dressings used in similar clinical conditions. In addition, real-life evidence confirmed the results obtained in clinical trials and economic models regardless the setting or the characteristics of the wounds treated. An improvement in the patients’ quality of life has been also documented by the use of TLC-NOSF.

Perspectives